FASIE (Foundation for Assistance to Small Innovative Enterprises) is one of the most famous Russian state funds supporting R&D projects. It supports focused on implementing new types of high-tech products and technologies, in spheres including information technology, biotechnology, medicine. Funds will be directed for creating a software system for monitoring molecular metrics using high throughput sequencing technologies.
In 2018 year Novel Software Systems got a grant from FASIE and started project realization in autumn. The goal of the project is to create a minimally invasive method of diagnostics for the recurrent glioblastoma, which can be applied to a broad range of patients. Innovative methods will be used, such as targeted needle multi-biopsy and extraction of circulating cancer DNA from spinal fluid.
Dmitry Shtokalo, CEO of Novel Software Systems, PhD, congratulates the fund on 25th anniversary and wishes more success in the years ahead.